Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Interest Expenses (2022 - 2025)

Historic Interest Expenses for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $5358.0.

  • bioAffinity Technologies' Interest Expenses fell 7523.0% to $5358.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $528931.0, marking a year-over-year increase of 50480.36%. This contributed to the annual value of $92475.0 for FY2024, which is 14909.09% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Interest Expenses is $5358.0, which was down 7523.0% from $483043.0 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Interest Expenses high stood at $896502.0 for Q3 2022, and its period low was $1360.0 during Q2 2023.
  • For the 4-year period, bioAffinity Technologies' Interest Expenses averaged around $144397.0, with its median value being $21940.0 (2024).
  • Per our database at Business Quant, bioAffinity Technologies' Interest Expenses tumbled by 9965.94% in 2023 and then skyrocketed by 207107.74% in 2025.
  • bioAffinity Technologies' Interest Expenses (Quarter) stood at $89290.0 in 2022, then crashed by 77.57% to $20025.0 in 2023, then rose by 25.07% to $25045.0 in 2024, then tumbled by 78.61% to $5358.0 in 2025.
  • Its Interest Expenses stands at $5358.0 for Q3 2025, versus $483043.0 for Q2 2025 and $15485.0 for Q1 2025.